Kevin Michael Coveney
Chief Financial Officer · Enveric Biosciences, Inc.
Individual
- 2024
- Jun 3, 2026
- 3
Other insiders active in the same sector
No other insider has filed at Kevin Michael Coveney's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $232.77M in AVAH purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Michael Coveney?
Kevin Michael Coveney is a corporate insider, tracked as Chief Financial Officer of Enveric Biosciences, Inc. (ENVB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Michael Coveney last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 3 filings going back to 2024.
